financetom
Business
financetom
/
Business
/
Reality TV slowdown drives Hollywood production decline
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Reality TV slowdown drives Hollywood production decline
Jul 17, 2024 12:54 PM

LOS ANGELES, July 17 (Reuters) - Los Angeles experienced

a hefty decline in reality TV production as Hollywood worked to

recover from dual labor strikes last year, according to

statistics released on Wednesday.

Actors, writers and crew members have been hoping for a

rebound in filming across all genres after last year's strikes

halted most production starting in July.

But from April through June this year, the number of

on-location filming days in the Los Angeles area fell 12.4%

below already low levels of a year earlier, a report from

permitting organization FilmLA found. The organization issued

permits for 5,749 shooting days during the quarter this year.

In the comparable period in 2023, production had already

started to wane ahead of a Writers Guild of America strike in

May. Filming dropped further when actors walked off the job in

July.

This year's decline was driven by a 56.9% drop in reality TV

production, the FilmLA report said.

The main reason, said FilmLA spokesman Philip Sokoloski, was

likely the widespread curtailing of production from the high

levels of recent years as investors demand profits from the

media industry's switch to streaming.

Also, some studios are waiting to start new projects in case

of another strike. The Teamsters union is trying to negotiate a

new labor agreement before its contract with Hollywood studios

expires on July 31.

Filming of scripted shows increased during the April-June

quarter. Drama productions rose 98.3% and comedy productions

more than doubled.

Feature-film production fell 3.3% in the quarter and

commercial production dropped 5.1%, FilmLA said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BioNTech Advances On Positive Phase 3 Breast Cancer Drug Data
BioNTech Advances On Positive Phase 3 Breast Cancer Drug Data
Sep 5, 2025
On Friday, BioNTech SE ( BNTX ) and its partner Duality Biologics (Suzhou) Co., Ltd. released topline data from a Phase 3 trial in China evaluating trastuzumab pamirtecan (BNT323/DB-1303) versus trastuzumab emtansine (T-DM1) for HER2-positive unresectable or metastatic breast cancer patients who have previously received trastuzumab and a taxane-based chemotherapy. The trial met its primary endpoint of progression-free survival at...
Ryan Specialty Launches New Collateralized Reinsurance Vehicle
Ryan Specialty Launches New Collateralized Reinsurance Vehicle
Sep 5, 2025
09:06 AM EDT, 09/05/2025 (MT Newswires) -- Ryan Specialty ( RYAN ) said Friday that it has launched a new collateralized reinsurance vehicle called Ryan Alternative Capital Re, via a strategic trading relationship with AXIS Capital ( AXS/PE ) . The new reinsurance vehicle has raised about $400 million in committed capital from funds managed by Flexpoint Ford and Sixth...
Mobile-health Network, Jospong Group to Launch Digital Health Platform in Ghana
Mobile-health Network, Jospong Group to Launch Digital Health Platform in Ghana
Sep 5, 2025
09:08 AM EDT, 09/05/2025 (MT Newswires) -- Mobile-health Network Solutions ( MNDR ) has signed a memorandum of understanding with Jospong Group to create a joint venture for launching Mobile-health's artificial intelligence-powered digital health platform in Ghana, the companies said Friday. Financial terms were not disclosed. The collaboration integrates Mobile-health's telehealth and AI-driven healthcare technology with Jospong's capital resources and...
WHO adds GLP-1 drugs for diabetes, others to essential medicines list
WHO adds GLP-1 drugs for diabetes, others to essential medicines list
Sep 5, 2025
LONDON, Sept 5 (Reuters) - The World Health Organization has added GLP-1 drugs to treat diabetes to its essential medicines list alongside treatments for cystic fibrosis and cancer, and said it hopes this will help improve global access to the costly drugs. The list, consisting of 523 medicines for adults and 374 for children, is a catalogue of the drugs...
Copyright 2023-2026 - www.financetom.com All Rights Reserved